NCT00376415View on ClinicalTrials.gov

A Safety Study of Lessertia Frutescens in Adults.

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions
Drug Safety
Interventions
DRUG

Lessertia Fructescens

Participants received 400mg lessertia fructescens leaf powder capsules twice daily for 3 months.

DRUG

Placebo

Participants received an identical placebo capsule twice daily for 3 months.

Trial Locations (1)

7535

Tiger Trial Centre, Tygerberg

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

University of the Western Cape

OTHER

lead

University of Missouri-Columbia

OTHER

NCT00376415 - A Safety Study of Lessertia Frutescens in Adults. | Biotech Hunter | Biotech Hunter